Novavax reported 2.01 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Adma Biologics 15.02 14.71 Mar/2026
AstraZeneca 29.59 2.3 Mar/2026
BioCryst Pharmaceuticals 6.06 1.07K Dec/2025
GlaxoSmithKline 14.87 3.72 Mar/2026
MannKind 201.15 102.55 Mar/2026
Merck 16.52 2.6 Mar/2026
Moderna 27.22 14.51 Jun/2023
Novartis 21.36 3.57 Mar/2026
Novavax 2.01 1.07 Dec/2025
Pfizer 9.32 5.16 Mar/2026
Sanofi 11.84 0.14 Mar/2026
Sarepta Therapeutics 27.27 0 Dec/2025
TG Therapeutics 10.76 2.32 Dec/2025